GM-CSF in Treating Patients With Relapsed Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Colony stimulating factors, such as GM CSF, may increase the number of immune cells found in bone marrow or peripheral blood. It is not yet known which GM-CSF regimen is more effective in treating patients with prostate cancer. PURPOSE: This randomized phase II trial is studying how well GM-CSF works in treating patients with relapsed prostate cancer.

Key facts

Study ID

NCT00908141

Run by

Case Comprehensive Cancer Center

People needed

17

Starts

2006-06-01

Expected to finish

2010-07-01

Last updated by the study team

2013-08-23

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.